Search Ontology:
ChEBI
(5R,6S,7S)-7-dodecanamido-8-(alpha-D-galactosyloxy)-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
- Term ID
- CHEBI:166871
- Synonyms
-
- (5R,6S,7S)-5,6-dihydroxy-7-dodecanamido-8-(alpha-D-galactosyloxy)-N-(6-phenylhexyl)octanamide
- (5R,6S,7S)-7-dodecanamido-8-(alpha-D-galactopyranosyloxy)-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
- alpha-GSA[12,6P]
- N-[(2S,3S,4R)-3,4-dihydroxy-8-oxo-8-[(6-phenylhexyl)amino]-1-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}octan-2-yl]dodecanamide
- Definition
- A synthetic alpha-galactosylsphingamide in which the galactose ring carries a (2S,3S,4R)-3,4-dihydroxy-2-(dodecanoylamino)-8-oxo-8-[(6-phenylhexyl)amino]octyl moiety at O-1.
- References
-
- PDBeChem:ELM
- PMID:31391251
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from (5R,6S,7S)-7-dodecanamido-8-(alpha-D-galactosyloxy)-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
Phenotype where environments contain (5R,6S,7S)-7-dodecanamido-8-(alpha-D-galactosyloxy)-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
Phenotype modified by environments containing (5R,6S,7S)-7-dodecanamido-8-(alpha-D-galactosyloxy)-5,6-dihydroxy-N-(6-phenylhexyl)octanamide
Human Disease Model